Current and emerging serious Gram-positive infections
Open Access
- 1 January 2005
- journal article
- review article
- Published by Elsevier in Clinical Microbiology & Infection
- Vol. 11 (s3), 22-28
- https://doi.org/10.1111/j.1469-0691.2005.01138.x
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Vancomycin‐ResistantStaphylococcus aureusin the Absence of Vancomycin ExposureClinical Infectious Diseases, 2004
- Endocarditis Caused byStaphylococcus aureuswith Reduced Susceptibility to VancomycinClinical Infectious Diseases, 2004
- Treatment of Infections Associated with Surgical ImplantsNew England Journal of Medicine, 2004
- Antibacterial susceptibility of a vancomycin-resistant Staphylococcus aureus strain isolated at the Hershey Medical CenterJournal of Antimicrobial Chemotherapy, 2003
- Infection with Vancomycin-ResistantStaphylococcus aureusContaining thevanAResistance GeneNew England Journal of Medicine, 2003
- Clinical Failures of Linezolid and Implications for the Clinical Microbiology LaboratoryEmerging Infectious Diseases, 2002
- Methicillin-Resistant, Quinupristin-Dalfopristin-Resistant Staphylococcus aureus with Reduced Sensitivity to GlycopeptidesJournal of Clinical Microbiology, 2001
- First clinical isolate of vancomycin-intermediate Staphylococcus aureus in a French hospitalThe Lancet, 1998
- Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibilityJournal of Antimicrobial Chemotherapy, 1997
- Mortality Associated with Nosocomial Bacteremia Due to Methicillin-Resistant Staphylococcus aureusClinical Infectious Diseases, 1995